These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1778716)

  • 1. Comment on "Dealing with discounting".
    Johannesson M; Levin LA
    Int J Technol Assess Health Care; 1991; 7(4):651-6. PubMed ID: 1778716
    [No Abstract]   [Full Text] [Related]  

  • 2. Dealing with discounting. An application to the cost-effectiveness of intracoronary thrombolysis with streptokinase.
    Martens L; van Doorslaer E
    Int J Technol Assess Health Care; 1990; 6(1):139-45. PubMed ID: 2113890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the use of t-PA as compared with streptokinase cost effective?
    Armentano R; Favaloro RG
    N Engl J Med; 1995 Oct; 333(15):1009-10. PubMed ID: 7666905
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of myocardial infarction in the elderly: admission and outcome on a coronary care unit.
    Haigh R; Castleden M; Woods K; Fletcher S; Bowns I; Gibson M; Soper J
    Health Trends; 1991-1992; 23(4):154-7. PubMed ID: 10117736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of primary percutaneous coronary intervention versus thrombolytic therapy for acute myocardial infarction.
    Selmer R; Halvorsen S; Myhre KI; Wisløff TF; Kristiansen IS
    Scand Cardiovasc J; 2005 Oct; 39(5):276-85. PubMed ID: 16269397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comments on the article "Comparison of the cost effectiveness of treatment of acute myocardial infarct with primary angioplasty and thrombolysis" by Golán et al].
    Vlcek J
    Vnitr Lek; 2003 Feb; 49(2):87-8. PubMed ID: 12728569
    [No Abstract]   [Full Text] [Related]  

  • 7. A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction.
    de Boer MJ; van Hout BA; Liem AL; Suryapranata H; Hoorntje JC; Zijlstra F
    Am J Cardiol; 1995 Oct; 76(11):830-3. PubMed ID: 7572666
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effectiveness of thrombolytic therapy for acute myocardial infarction.
    Castillo PA; Palmer CS; Halpern MT; Hatziandreu EJ; Gersh BJ
    Ann Pharmacother; 1997 May; 31(5):596-603. PubMed ID: 9161657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary angioplasty versus thrombolysis for acute ST-elevation myocardial infarction: an economic analysis of the National Infarct Angioplasty project.
    Wailoo A; Goodacre S; Sampson F; Alava MH; Asseburg C; Palmer S; Sculpher M; Abrams K; de Belder M; Gray H
    Heart; 2010 May; 96(9):668-72. PubMed ID: 19508972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospital cost of acute myocardial infarction in the thrombolytic era.
    Mahon NG; Rahallaigh PO; O'Sullivan JB; Codd MB; McCann HA; Sugrue DD
    Ir Med J; 2000 Jun; 93(4):122. PubMed ID: 11037575
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acute myocardial infarct: thrombolysis of coronary angioplasty?].
    Rickenbacher P
    Praxis (Bern 1994); 1998 Feb; 87(6):183-5. PubMed ID: 9531811
    [No Abstract]   [Full Text] [Related]  

  • 12. Is a 3-day hospitalization cost-effective for patients after uncomplicated acute myocardial infarction (AMI)?
    Koenig C; Stevermer J
    J Fam Pract; 2000 Jun; 49(6):574. PubMed ID: 10923562
    [No Abstract]   [Full Text] [Related]  

  • 13. Reperfusion in acute myocardial infarction. Ensuring early reperfusion, by whatever means, is the best strategy for now.
    Robinson NM; Timmis AD
    BMJ; 2000 May; 320(7246):1354-5. PubMed ID: 10818008
    [No Abstract]   [Full Text] [Related]  

  • 14. Is the use of t-PA as compared with streptokinase cost effective?
    Rose EA
    N Engl J Med; 1995 Oct; 333(15):1009; author reply 1010. PubMed ID: 7666904
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cost-effectiveness of primary PTCA and thrombolysis in the treatment of acute myocardial infarction].
    Sagmeister M; Amann FW; Follath F
    Schweiz Med Wochenschr; 2000 Aug; 130(33):1146-51. PubMed ID: 11005104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of prehospital versus inhospital thrombolysis in acute myocardial infarction.
    Araújo DV; Tura BR; Brasileiro AL; Luz Neto H; Pavão AL; Teich V
    Arq Bras Cardiol; 2008 Feb; 90(2):91-8. PubMed ID: 18392380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When analyses are invalidated by erroneous assumptions.
    Terkelsen CJ; Lassen JF; Nørgaard BL; Nielsen TT; Andersen HR
    Int J Technol Assess Health Care; 2005; 21(3):414-5; author reply 416-20. PubMed ID: 16110724
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction.
    Krumholz HM; Pasternak RC; Weinstein MC; Friesinger GC; Ridker PM; Tosteson AN; Goldman L
    N Engl J Med; 1992 Jul; 327(1):7-13. PubMed ID: 1598117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimated gain in life expectancy. A simple tool to select optimal reperfusion treatment in individual patients with evolving myocardial infarction.
    Boersma H; van der Vlugt MJ; Arnold AE; Deckers JW; Simoons ML
    Eur Heart J; 1996 Jan; 17(1):64-75. PubMed ID: 8682132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the cost of a systematic early reperfusion of the infarction artery by primary or salvage angioplasty].
    Chevalier B
    Ann Cardiol Angeiol (Paris); 1997 Nov; 46(9):576-7. PubMed ID: 9538369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.